Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomas
- Conditions
- T1 bulky/T2 favorable Glottic carcinoma, squamous cell carcinoma
- Registration Number
- JPRN-UMIN000023416
- Lead Sponsor
- agoya University Graduate School of Medicine, Department of Radiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Not provided
(1) unable to take oral S-1; (2) with a history of severe allergy; (3) severe clinical infection; (4) with active double cancer including simultaneous cancer or metachronous cancer within 5 years, except for in situ or intramucosal carcinoma; (5) being pregnant or breast feeding; (6) with mental disease interfering participating the trial; (7) with severe bone marrow dysfunction; (8) with the history of kidney disease, such as getting dialysis; (9) with the history of severe liver disease; (10)with the history of severe lung disease, such as interstitial pneumonia of pulmonary fibrosis; (11) with the history of collagen disease; (12) with uncontrolled diabetes mellitus or insulin-dependent diabetes mellitus; (13) with uncontrolled hypertension; (14) cardiovascular diseases with clinical significance, such as heart failure, history of myocardial infarction or angina in the past half year; (15) taking drugs as follows; other pyrimidine compound- anticancer drug or flucytosine ; (16) jugged as inadequate case by doctor in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method